Literature DB >> 1979834

Graded cytopathogenicity of the human immunodeficiency virus (HIV) in the course of HIV infection.

K E Schneweis1, J P Kleim, E Bailly, D Niese, N Wagner, H H Brackmann.   

Abstract

To determine whether the biological variability of HIV-1 has any clinical significance, the highly variable cytopathogenicity of 153 HIV-1 strains, isolated from 119 hemophiliacs, was related to the number of CD4+ lymphocytes present in the patient's blood at the time of virus isolation. It was shown that the cytopathogenicity of the HIV-1 isolates was inversely correlated with the number of CD4+ lymphocytes. The highest CD4+ cell number were observed in 34 latently infected patients characterized by HIV seropositivity, failure of virus isolation, and detection of viral DNA by the polymerase chain reaction. Cytopathogenicity of the HIV-1 isolates was a reliable prognostic marker and correlated well with other less-sensitive prognostic parameters, including the detection of infectious virus and p24 antigen in the plasma, and the decline of p24 antibody in the serum. The results suggest that the viral isolates - if not subjected to extensive passage - represent in vivo variants selected from a heterogeneous viral population according to the particular immunological conditions of the host.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979834     DOI: 10.1007/bf00195250

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  27 in total

1.  Natural history of HIV-infection in hemophiliacs: clinical, immunological, and virological findings.

Authors:  T Kamradt; D Niese; K E Schneweis; H H Brackmann; B Kamps; B van Loo; U Hammerstein
Journal:  Klin Wochenschr       Date:  1989-10-17

2.  Differential ability of human immunodeficiency virus isolates to productively infect human cells.

Authors:  L A Evans; T M McHugh; D P Stites; J A Levy
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

3.  Isolation of variants of lymphocytopathic retroviruses from the peripheral blood and cerebrospinal fluid of patients with ARC or AIDS.

Authors:  H Rübsamen-Waigmann; W B Becker; E B Helm; R Brodt; H Fischer; K Henco; H D Brede
Journal:  J Med Virol       Date:  1986-08       Impact factor: 2.327

4.  HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions.

Authors:  M Goodenow; T Huet; W Saurin; S Kwok; J Sninsky; S Wain-Hobson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

5.  Non-cytocidal natural variants of human immunodeficiency virus isolated from AIDS patients with neurological disorders.

Authors:  R Anand; F Siegal; C Reed; T Cheung; S Forlenza; J Moore
Journal:  Lancet       Date:  1987-08-01       Impact factor: 79.321

6.  Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.

Authors:  M Tersmette; R A Gruters; F de Wolf; R E de Goede; J M Lange; P T Schellekens; J Goudsmit; H G Huisman; F Miedema
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

Authors:  M Tersmette; R E de Goede; B J Al; I N Winkel; R A Gruters; H T Cuypers; H G Huisman; F Miedema
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

8.  Extensive variation of human immunodeficiency virus type-1 in vivo.

Authors:  M S Saag; B H Hahn; J Gibbons; Y Li; E S Parks; W P Parks; G M Shaw
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

9.  Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals.

Authors:  M C Psallidopoulos; S M Schnittman; L M Thompson; M Baseler; A S Fauci; H C Lane; N P Salzman
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

10.  Variable and conserved neutralization antigens of human immunodeficiency virus.

Authors:  R A Weiss; P R Clapham; J N Weber; A G Dalgleish; L A Lasky; P W Berman
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

View more
  9 in total

Review 1.  Guarding against the most dangerous emerging pathogens.

Authors:  P W Ewald
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

2.  HIV colonizing peripheral blood monocytes follows lymphocytic isolates in shifting from NSI to SI genotype.

Authors:  A Witt; R Kaiser; A Mayer; R Rolf; B Matz; K E Schneweis
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection.

Authors:  L Q Zhang; P MacKenzie; A Cleland; E C Holmes; A J Brown; P Simmonds
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

4.  Expression of the HIV-1 Nef protein in the baculovirus system: investigation of anti-Nef antibodies response in human sera and subcellular localization of Nef.

Authors:  N Kienzle; M Enders; M Buck; H Siakkou; S Jahn; G Petzold; K E Schneweis; M Bachmann; W E Müller; N Müller-Lantzsch
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  Latent human herpesvirus-6 DNA is sparsely distributed in peripheral blood lymphocytes of healthy adults and patients with lymphocytic disorders.

Authors:  T Sandhoff; J P Kleim; K E Schneweis
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

Review 6.  Factor VIII, HIV and AIDS in haemophiliacs: an analysis of their relationship.

Authors:  E Papadopulos-Eleopulos; V F Turner; J M Papadimitriou; D Causer
Journal:  Genetica       Date:  1995       Impact factor: 1.082

7.  Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication.

Authors:  J P Kleim; R Bender; R Kirsch; C Meichsner; A Paessens; M Rösner; H Rübsamen-Waigmann; R Kaiser; M Wichers; K E Schneweis
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

8.  Male-to-female transmission of HIV in a cohort of hemophiliacs--frequency, risk factors and effect of sexual counseling.

Authors:  J K Rockstroh; S Ewig; T Bauer; G Lüchters; J Oldenburg; E Bailly; R Kaiser; K E Schneweis; H H Brackmann; H J Dengler
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

9.  An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data.

Authors:  Katarzyna Bozek; Manon Eckhardt; Saleta Sierra; Maria Anders; Rolf Kaiser; Hans-Georg Kräusslich; Barbara Müller; Thomas Lengauer
Journal:  Retrovirology       Date:  2012-07-25       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.